Former US Food and Drug Administration principal deputy commissioner Josh Sharfstein is no longer in strong contention to be President Joe Biden’s FDA commissioner, but surprisingly that doesn’t mean acting commissioner Janet Woodcock is a shoo-in for the job, three former FDA officials say.
While the White House’s decision had seemed to be narrowed down to this two-party race, sleeper candidates may now have a shot.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?